The animal experiment results indicated that transferring CD34+ UCBSC- IL-21 into A2780 ovarian cancer xenograft-bearing nude mice augmented the therapeutic effect on ovarian cancer, however, IL-21 expression was gradually decreased in the mouse tumor sites 21 days posttransplantation[20]. The gene discussed is CD34; the disease is ovarian cancer.